Cardiac 99mTc sestamibi SPECT and 18F FDG PET as viability markers in takotsubo cardiomyopathy-Reference-Cited by-同舟云学术

Cardiac 99mTc sestamibi SPECT and 18F FDG PET as viability markers in takotsubo cardiomyopathy

Published:2014-05-23 Issue:7 Volume:30 Page:1407-1416
ISSN:1569-5794
Container-title:The International Journal of Cardiovascular Imaging
language:en
Short-container-title:Int J Cardiovasc Imaging

Author:

Christensen Thomas Emil,Bang Lia Evi,Holmvang Lene,Ghotbi Adam Ali,Lassen Martin Lyngby,Andersen Flemming,Ihlemann Nikolaj,Andersson Hedvig,Grande Peer,Kjaer Andreas,Hasbak Philip

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s10554-014-0453-5.pdf

Reference45 articles.

1. Partington SL, Kwong RY, Dorbala S (2011) Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev 16(4):381–395

2. Schelbert HR (1994) Metabolic imaging to assess myocardial viability. J Nucl Med 35(4 Suppl):8S–14S

3. Hendel RC, Berman DS, Di Carli MF, Heidenreich PA, Henkin RE, Pellikka PA, Pohost GM, Williams KA (2009) ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American college of cardiology foundation appropriate use criteria task force, the American society of nuclear cardiology, the American college of radiology, the American heart association, the american society of echocardiography, the society of cardiovascular computed tomography, the society for cardiovascular magnetic resonance, and the society of nuclear medicine. J Am Coll Cardiol 53(23):2201–2229

4. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, BenLamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 14(8):803–869

5. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel F, Busemann SE, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, McKiddie F, O’Connor M, Prvulovich E, Underwood R, van Eck-Smit B (2005) EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 32(7):855–897

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pheochromocytoma Induced Coronary Vasospasm and Takotsubo Cardiomyopathy;Journal of Medical Clinical Case Reports;2024-06-19

2. Impact of Coronary Microvascular Dysfunction in Takotsubo Syndrome: Cause, Consequence or Both?;Reviews in Cardiovascular Medicine;2024-05-11

3. The characteristics of Japanese guidelines on diagnosis and treatment of cardiac sarcoidosis compared with the previous guidelines;SARCOIDOSIS VASC DIF;2022

4. Novel Imaging and Genetic Risk Markers in Takotsubo Syndrome;Frontiers in Cardiovascular Medicine;2021-08-17

5. Pathophysiology of Takotsubo Syndrome;Journal of the American College of Cardiology;2021-02